17 completed, 7 unknown, 1 not yet recruiting, 1 terminated. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 17, Unknown 7, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study Conventional 24-week glucocorticoid regimen, short-term course (12 week) glucocorticoid regimen - Idiopathic Nephrotic Syndrome | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 224 | 2026-01-01 | 2025-09-03 |
| Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome Atorvastatin - Dyslipidaemia | Phase 4 | Completed | National Institute of Kidney Disease and Urology (NIKDU) | 100 | 2024-01-27 | 2026-03-27 |
| Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome. Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB). - Nephrotic Syndrome | Phase 4 | Unknown | Ain Shams University | 90 | 2023-08-01 | 2023-08-01 |
| The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children Huaiqihuang granule, Prednisone, Levamisole placebo - Nephrotic Syndrome in Children | Phase 4 | Unknown | Jianhua Zhou | 402 | 2023-04-26 | 2024-06-21 |
| Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome Dapagliflozin 10mg Tab - Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Completed | Ain Shams University | 60 | 2022-08-01 | 2023-09-07 |
| Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients Cyclosporine Capsule - Nephrotic Syndrome | Phase 4 | Unknown | Alexandria University | 74 | 2022-04-17 | 2023-12-11 |
| Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome Tacrolimus, Mycophenolate Mofetil - Nephrotic Syndrome in Children | Phase 4 | Completed | The Children's Hospital of Zhejiang University School of Medicine | 270 | 2019-11-12 | 2023-10-17 |
| Steroid Sensitive Nephrotic Syndrome in Children Corticosteroids - Nephrotic Syndrome in Children | Phase 4 | Terminated | Wayne State University | 34 | 2019-08-06 | 2022-05-02 |
| ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children Acthar Gel 80 UNT/ML Injectable Solution - Steroid-Resistant Nephrotic Syndrome | Phase 4 | Withdrawn | Rhode Island Hospital | 2018-06-01 | 2019-04-23 | |
| Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy Prednisolone, Alfacalcidol - Minimal Change Disease, Nephrotic Syndrome | Phase 4 | Completed | University of Aarhus | 71 | 2018-05-01 | 2025-01-24 |
| Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome Prednisone - Nephrotic Syndrome, Minimal Change | Phase 4 | Unknown | Rabin Medical Center | 75 | 2016-03-01 | 2016-01-12 |
| Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema Acetazolamide and Hydrochlorothiazide Followed by Furosemide, Furosemide and Hydrochlorothiazide Followed by Furosemide - Nephrotic Syndrome, Edema | Phase 4 | Completed | Shiraz University of Medical Sciences | 20 | 2015-04-01 | 2016-02-23 |
| Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome Rituximab, Tacrolimus - Nephrotic Syndrome | Phase 4 | Unknown | Nilratan Sircar Medical College | 120 | 2015-03-15 | 2022-04-07 |
| Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. Cholecalciferol vial (100 000 UI) - Chronic Kidney Disease, Renal Transplantation | Phase 4 | Completed | Hospices Civils de Lyon | 43 | 2014-09-01 | 2025-09-04 |
| Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome Mycophenolate mofetil - Nephrotic Syndrome | Phase 4 | Completed | Seoul National University Hospital | 34 | 2013-09-01 | 2017-07-06 |
| A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome Tacrolimus, Prednisolone - MCNS, Minimal Change Nephrotic Syndrome (MCNS) | Phase 4 | Completed | Astellas Pharma Korea, Inc. | 144 | 2012-07-16 | 2024-10-31 |
| Pharmacokinetics of Tacrolimus in Children Tacrolimus - Nephrotic Syndrome | Phase 4 | Completed | Shandong University | 28 | 2012-01-01 | 2017-11-20 |
| Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Repository Corticotropin Injection, Placebo - Proteinuria, Idiopathic Membranous Nephropathy | Phase 4 | Completed | Mallinckrodt | 60 | 2011-08-01 | 2019-11-20 |
| Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Myfortic plus low-dose steroid, Prednisolone - Nephrosis, Lipoid | Phase 4 | Completed | The University of Hong Kong | 20 | 2010-09-01 | 2018-06-01 |
| Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children Tacrolimus - Nephrotic Syndrome | Phase 4 | Completed | Seoul National University Hospital | 77 | 2010-07-01 | 2019-02-07 |
Showing 20 of 27. Sign in to see all of them.
Nephrotic Syndrome (22) · Nephrosis, Lipoid (8) · Proteinuria (4) · Glomerulonephritis (2) · Glomerulonephritis, Membranous (2) · Nephritis (2) · Diabetic Nephropathies (1) · Dyslipidemias (1) · Edema (1) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · IgA Vasculitis (1) · Kidney Diseases (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (27) · Female Urogenital Diseases and Pregnancy Complications (27) · Male Urogenital Diseases (27) · Urogenital Diseases (27) · Urologic Diseases (27) · Kidney Diseases (26) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (5) · Urination Disorders (4) · Urological Manifestations (4) · Immune System Diseases (3) · Nephritis (3) · Autoimmune Diseases (2) · Glomerulonephritis (2)
Tacrolimus (6) · Prednisolone (4) · Mycophenolic Acid (3) · Prednisone (3) · Adrenal Cortex Hormones (2) · Adrenocorticotropic Hormone (2) · dapagliflozin (2) · Acetazolamide (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Atorvastatin (1) · Calcineurin Inhibitors (1) · Congresses as Topic (1) · Cyclosporine (1) · Furosemide (1) · Heptavalent Pneumococcal Conjugate Vaccine (1)
Ain Shams University (2) · Seoul National University Hospital (2) · Alexandria University (1) · Arizona Kidney Disease and Hypertension Center (1) · Astellas Pharma Korea, Inc. (1) · Columbia University (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Hospices Civils de Lyon (1) · Imperial College Healthcare NHS Trust (1) · Institute of Child Health (1) · Jianhua Zhou (1) · Mallinckrodt (1) · National Institute of Kidney Disease and Urology (NIKDU) (1) · National and Kapodistrian University of Athens (1) · Nilratan Sircar Medical College (1)
China (5) · United States (5) · South Korea (3) · Egypt (2) · United Kingdom (2) · Bangladesh (1) · Canada (1) · Chile (1) · Denmark (1) · Finland (1) · France (1) · Greece (1) · India (1) · Israel (1) · Mexico (1)
Amit Dagan, Dr. (1) · Biswanath Basu (1) · Christina Liakou, MD (1) · Gerald B Appel, MD (1) · Hee Gyung Aurea Kang, M.D., Ph.D. (1) · James A. Tumlin, MD (1) · Jianhua Mao, MD (1) · Jianhua Zhou, Dr. (1) · Justine Bacchetta, MD (1) · Maria Theodoridou, Dr (1) · Matti Nuutinen, M.D., Ph.D. (1) · Megan Griffith, MBChBPhDFRCP (1)
PMID 35230699, PMID 39513526, PMID 12944064, PMID 14655180, PMID 16961774, PMID 17489822, PMID 17989649, PMID 21626222, PMID 22722778, PMID 23343906, PMID 23813218, PMID 24009220, PMID 24159603, PMID 31769845, PMID 31873802, PMID 34247632, PMID 34778952, PMID 3588043, PMID 36405821, PMID 36853224, PMID 39171624, PMID 40337980, PMID 40354041, PMID 41905593, PMID 7479966, PMID 7911091, PMID 9176846, PMID 9469489
2009 (1)